Literature DB >> 2692747

Platelet-derived growth factors.

K Miyazono1, F Takaku.   

Abstract

Blood platelets are a rich source of growth factors, including platelet-derived growth factor, platelet-derived endothelial cell growth factor, and transforming growth factor beta. Platelet-derived growth factor stimulates the growth of mesenchymal cells such as fibroblasts and vascular smooth muscle cells, whereas platelet-derived endothelial cell growth factor is a mitogen for vascular endothelial cells. Transforming growth factor beta is a bifunctional regulator of cellular growth, but acts as a potent inhibitor for most cell types. Most of the growth regulatory substances in platelets have been reported to reside in platelet alpha-granules, but platelet-derived endothelial cell growth factor appears to be present in platelet cytoplasm. These growth factors may act at sites of injury as wound hormones. Moreover, they play important roles for some pathological conditions such as atherosclerosis, myelofibrosis, connective tissue diseases, and neoplastic disorders.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2692747     DOI: 10.1016/0268-960x(89)90034-9

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  9 in total

1.  Blood components for topical use in tissue regeneration: evaluation of corneal lesions treated with platelet lysate and considerations on repair mechanisms.

Authors:  Walter Geremicca; Carla Fonte; Sisto Vecchio
Journal:  Blood Transfus       Date:  2010-04       Impact factor: 3.443

2.  Determining the Effect of Preparation and Storage: An Effort to Streamline Platelet Components as a Source of Growth Factors for Clinical Application.

Authors:  Atul Sonker; Anju Dubey
Journal:  Transfus Med Hemother       Date:  2015-01-29       Impact factor: 3.747

3.  A prespore-cell-inducing factor in Dictyostelium discoideum: its purification and characterization.

Authors:  M Nakagawa; A A Oohata; H Tojo; S Fujii
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

4.  Sequential changes in the cell mediators of peritoneal and wound fluids after surgery.

Authors:  A Tokunaga; M Onda; I Fujita; T Okuda; T Mizutani; T Kiyama; N Matsukura; T K Hunt
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

5.  Thrombospondin co-localises with TGF beta and IGF-I in the extracellular matrix of human osteoblast-like cells and is modulated by 17 beta estradiol.

Authors:  M Slater; J Patava; R S Mason
Journal:  Experientia       Date:  1995-03-15

6.  Improved bone healing by angiogenic factor-enriched platelet-rich plasma and its synergistic enhancement by bone morphogenetic protein-2.

Authors:  Eun-Jin Park; Eun-Seok Kim; Hans-Peter Weber; Robert F Wright; David J Mooney
Journal:  Int J Oral Maxillofac Implants       Date:  2008 Sep-Oct       Impact factor: 2.804

7.  Platelet growth factors from allogeneic platelet-rich plasma for clinical improvement in split-thickness skin graft.

Authors:  Atul Sonker; Anju Dubey; Ankur Bhatnagar; Rajendra Chaudhary
Journal:  Asian J Transfus Sci       Date:  2015 Jul-Dec

Review 8.  Research progress in the mechanism of effect of PRP in bone deficiency healing.

Authors:  Ning Zhang; Yong-Ping Wu; Sheng-Jun Qian; Chong Teng; Shuai Chen; Hang Li
Journal:  ScientificWorldJournal       Date:  2013-04-04

9.  Inhibition of tumor growth by elimination of granulocytes.

Authors:  L A Pekarek; B A Starr; A Y Toledano; H Schreiber
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.